News
IMVACS Clinical Trial Registration on PACTR
05 February 2025
The IMVACS Clinical Trial has been successfully registered on the Pan African Clinical Trials Registry
a new EVI clinical trial to protect pregnant women against malaria
EVI has launched a Phase II clinical trial in Mali to evaluate the R21 malaria vaccine in women of childbearing potential.
Data Safety Monitoring Board Set up & organizational meeting
31st March 2025
The IMVACS Consortium held its initial organizational meeting with the newly appointed Data Safety Monitoring Board members.
CoSAV-R21 trial
In June 2025, Epicentre/MSF in collaboration with other IMVACS partners, LSTM and CNRST, is about to launch the CoSAV-R21 trial in Chad.
Trial Steering Committee
30th April 2025
IMVACS Consortium has officially set up its Trial Steering Committee.
Al-Sumait Prize
Professor Halidou Tinto from CNRST/IRSS, one of the IMVACS key partners, won the prestigious Al-Sumait Prize.
Prof. Tinto at Serum Institute of India
From June 1st to 4th, 2025, Professor Halidou Tinto visited the Serum Institute of India, in Pune, India.
IMVACS at ASTMH 2025
9-13th November
Some members of our team proudly attended the ASTMH 2025 Annual Meeting in Toronto, Canada.
World Children’s Day 2025
On 20th November 2025, the IMVACS Consortium celebrates the World Children’s Day.
What strategy should be used to maximize the impact of the R21/Matrix-M malaria vaccine?
A lesson from the CoSAV-R21 trial
